This content was published on 03 August 2022 – 02:27
Lima, Aug 2 (EFE) .- The Peruvian Ombudsman asked the Government on Tuesday to “prioritize the evaluation of the incorporation” of the monkeypox vaccine in the face of the “high number of cases” reported by this disease, which they already add up to 313 nationwide.
“We ask the Ministry of Health to prioritize the evaluation of the incorporation of the monkeypox vaccine, taking into account recommendations issued by the WHO (World Health Organization) in relation to this multinational outbreak and the high number of cases,” the autonomous body wrote in their social networks.
The Ombudsman added that, according to the national plan for preparation and response to this disease, Peru is currently in a phase of “community transmission”, so “it is urgent to strengthen health services to prevent and reduce the impact of smallpox.” simian”.
On a possible acquisition of the vaccine against this virus, the Minister of Health, Jorge López, ruled last week, who indicated that, after the WHO declared an international emergency due to the current outbreak, his sector was evaluating it.
“Of all the indications that the WHO has given, we already have 99% in our country (…) the only thing we lack is the vaccine, nothing else, which is currently being evaluated by the expert committee (to ) to see if we are going to have the need to buy this vaccine for our risk group,” he said.
According to the latest official report, Peru has recorded to date a total of 313 cases of monkeypox in 9 regions of the country, with Lima, where a third of the population lives, being the most affected, with 270 infections.
The rest of the cases were detected in Callao (20), La Libertad (12), Ica (3), Lima Provinces (2), Cusco (2), Tacna (1), Loreto (1) and Junín (1).
All the patients received medical assistance and 99 of them have already been discharged, according to the report.
The first case of monkeypox in Peru was reported on June 26 and last Monday the country’s health authorities confirmed the first death of a patient who had contracted the disease, although they did not blame this virus for his death.
The 41-year-old man had been admitted to a hospital in Lima due to respiratory distress and skin lesions with a history of HIV infection and tuberculosis, and after having abandoned his antiretroviral treatment.
The Ministry of Health pointed out that the patient lost his life due to acute kidney failure, respiratory failure, and septic shock. EFE
csr/cpy
� EFE 2022. The redistribution and redistribution of all or part of the contents of EFE services is expressly prohibited, without the prior and express consent of Agencia EFE SA
–
